Member Exclusive

Pharma is opening the doors for external molecule designers

The Open Innovation model is being explored by Pharma and it holds great promise for all parties in the Life Science ecosystem. In a move to further boost early drug discovery innovation several OI platforms in Pharma RnD have been established in order to allow external partner to much more easily test their molecules for biological activity.

Go to the profile of Niclas Nilsson
Oct 29, 2015
2
0

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.